Voyager Therapeutics, Inc. Other Current Assets
Voyager Therapeutics, Inc. (VYGR) had Other Current Assets of $2.28 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-03-09
- 2025-12-31: Other Assets, Current $2.28M.
- 2024-12-31: Other Assets, Current $2.87M.
- 2023-12-31: Other Assets, Current $2.63M.
- 2022-12-31: Other Assets, Current $4.23M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2025-12-31 | $2.28M 10-K · filed 2026-03-09 | |
| 2024-12-31 | $2.87M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $2.63M 10-K · filed 2025-03-11 | |
| 2022-12-31 | $4.23M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $1.70M 10-K · filed 2023-03-07 | |
| 2020-12-31 | $1.57M 10-K · filed 2022-03-08 | |
| 2019-12-31 | $1.40M 10-K · filed 2021-02-25 | $1.95M 10-K · filed 2020-03-03 |
| 2018-12-31 | $1.36M 10-K · filed 2020-03-03 | |
| 2017-12-31 | $766.00K 10-K · filed 2019-02-26 | |
| 2016-12-31 | $1.96M 10-K · filed 2018-03-14 | $430.00K 10-K · filed 2017-03-15 |
| 2015-12-31 | $424.00K 10-K · filed 2017-03-15 | $382.00K 10-K · filed 2016-03-17 |
| 2015-09-30 | $263.00K 10-Q · filed 2015-12-17 | |
| 2014-12-31 | $406.00K 10-K · filed 2016-03-17 | $423.00K 10-Q · filed 2015-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |